...
首页> 外文期刊>International Journal of Pediatrics and Adolescent Medicine >New or vanishing frontiers: LACC1-associated juvenile arthritis
【24h】

New or vanishing frontiers: LACC1-associated juvenile arthritis

机译:新的或消失的边界: lacc1 - 相关的青少年关节炎

获取原文
           

摘要

BackgroundThe classification and pathogenic basis of juvenile idiopathic arthritis (JIA) are a subject of some controversy. Essentially, JIA is an exclusion diagnosis that represents a phenotypically heterogeneous group of arthritis of unknown origin. Familial aggregation of JIA supports the concept of genetic influence in the pathogenesis of JIA.ObjectiveTo present the spectrum of laccase domain-containing 1 (LACC1)-associated juvenile arthritis with clinical, biochemical, and molecular genetic data of a cohort of 43 patients, including 11 previously unpublished cases.MethodsWe studied 11 patients with different categories of juvenile idiopathic arthritis from 5 consanguineous families, all from Saudi Arabia, except 2 patients who were of Jordanian ethnicity. Whole-exome sequencing was used to identify the disease-causing variant of LACC1. We also reviewed the clinical spectrum and molecular genetic data of previously published cases of LACC1-associated juvenile arthritis.ResultsThis study describes 43 (29 females, 14 males) patients from consanguineous multiplex families. Most of the included patients were of Arab origin with 86% having early onset disease. The most frequent categories were systemic (19 patients) and rheumatoid factor-negative polyarticular (19 patients). Thirty-seven (86%) had progressive erosive arthritis and 10 (23.3%) had persistent limb lymphedema. None of the patients had features of macrophage activation syndrome. Genetic analysis confirmed LACC1 variant in all patients; 22 patients had common founder mutation (LACC1: c.850T?>?C,p.C284R), while the others showed different LACC1 variants. All patients were treated aggressively with methotrexate and sequential biologic agents. Most of them showed a poor response to treatment.ConclusionThis report expands the pathogenic variants of LACC1 and the clinical spectrum associated with this genetic subset of juvenile arthritis. The predominance of autosomal-recessive inheritance and strong genetic evidence allowed us to propose LACC1-associated juvenile arthritis as a distinct disorder.
机译:背景技术少年特发性关节炎(贾)的分类和致病基础是一些争议的主题。基本上,贾是一种排除诊断,代表了未知起源的表型异质关节炎。贾的家族聚集支持贾氏菌病发生的遗传影响概念。介绍含漆域的1(LACC1) - 分配的幼年关节炎,临床,生化和分子遗传数据,43名患者的群组,包括11以前未发表的案例。近期研究了来自沙特阿拉伯的5名近亲家族的11名患有不同类别的少年特发性关节炎的患者,除了2名与约旦种族的患者。全外测序用于鉴定LAC1的引起疾病变体。我们还审查了先前公布了LacC1相关幼年关节炎病例的临床频谱和分子遗传数据。患者描述了43(29名女性,14名男性)来自近亲多重家族的患者。其中大多数患者都是阿拉伯血症,86%有早期发作疾病。最常见的类别是全身(19名患者)和类风湿性因子阴性多体(19名患者)。三十七(86%)具有渐进的糜烂性关节炎,10(23.3%)有持续的肢体淋巴米肿瘤。没有患者没有巨噬细胞激活综合征的特征。遗传分析证实了所有患者的LACC1变异; 22例患者具有常见的创始人突变(LAC1:C.850T?> C,P.C284R),而其他患者显示不同的LAC1变体。所有患者均受甲氨蝶呤和序贯生物剂的积极治疗。其中大多数表现出对治疗的反应较差。结论该报告扩增了LACC1的致病变体和与幼年关节炎的这种遗传子集相关的临床谱。常染色体隐性遗传和强的遗传证据的优势使我们将LACC1相关的幼年关节炎作为一种明显的病症。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号